Author of

• 28120

  +

  Poster Session (ID 8)

  • Event: ACLC 2018
  • Type: Poster Session
  • Track:
  • Presentations: 2
  • Moderators:
  • Coordinates: 11/07/2018, 00:00 - 00:00, Poster Hall

  • 28170

    +

    P006 - Evaluation of Efficacy and Safety of Uniportal Segmentectomy in the Treatment of Small Lung Nodule (ID 125)

    00:00 - 00:00  |  Author(s): H. Liu
    • Abstract

    Background:
    Uniportal segmentectomy is a therapeutic option for small lung nodule, but the debate over uniportal segmentectomy still remains. The aim of this study is to evaluate of efficacy and safety of uniportal segmentectomy in the treatment of small lung nodule.
    
    
    Method:
    A total of 85 patients who underwent uniportal segmentectomy or subsegmentectomy between January 2017 and September 2018 in Liaoning Cancer Hospital. The clinical data of these patients were retrospectively analyzed, including operation time, number of lymph nodes dissected and postoperative mortality, postoperative complications, postoperative intubation time, and postoperative hospital stay.
    
    
    Results:
    The surgery procedure was anatomical pulmonary segmentectomy or subsegmentectomy. Uniportal segmentectomy was in 81 cases, and subsegmentectomy was in 4 cases. The median operation time was 243 minutes (range, 60-405 minutes), median number of lymph nodes dissected was 14 (range, 0-31), median postoperative intubation time was 5 days (range, 1-9 days), median postoperative hospital stay was 8 days (range, 3-19 days). The postoperative complications were pneumonia 1 case (1.2%), fever 9 cases (10.6%), hemoptysis 1 case (1.2%), air leak 1 case (1.2%), atrial fibrillation 1 case (1.2%), and subcutaneous hydrops 2 cases (2.4%). There was no severe postoperative complications, including death, bleeding, reoperation, and bronchopleural fistula.
    
    
    Conclusion:
    Uniportal segmentectomy is a safe and feasible technique for treating small pulmonary lesions, with acceptable postoperative complications and mortality.

  • 28148

    +

    P017 - Investigation of Mediastinal Lymph Node Metastasis in Non-Small Cell Lung Cancer (ID 72)

    00:00 - 00:00  |  Author(s): H. Liu
    • Abstract

    Background:
    To investigate the distribution of mediastinal lymph node metastasis in non-small cell lung cancer(NSCLC) and provide evidence for the range of mediastinal lymph node dissection.
    
    
    Method:
    Retrospectively analyze NSCLC patients underwent systematic lymph node dissection and confirmed mediastinal lymph nodes metastasis postoperatively.
    
    
    Results:
    78 cases were enrolled in this research. 11 in left upper lobe (14.1%), 27 in left lower lobe (34.6%), 16 in right upper lobe (20.5%), 4 in right middle lobe (5.1%), 20 in right lower lobe (25.6%). Among all left upper lobe cancers, 10 had upper mediastinal lymph node metastasis (66.7%); 5 subcarinal metastasis (33.3%), and no lower metastasis cases; in left lower cancers, 5 had upper mediastinal lymph node metastasis (13.5%), 17 subcarinal metastasis (45.9%), and 15 lower mediastinal metastasis (40.5%). For right upper lobe, 16 had upper mediastinal metastasis (64%), 6 subcarinal metastasis (24%), and 3 lower mediastinal metastasis (12%); for right middle lobe, 2 had upper mediastinal metastasis (33.3%), 3 subcarinal metastasis (50%), and 1 lower mediastinal metastasis (16.7%); for right lower lobe, 12 had upper mediastinal lymph node metastasis (34.3%), 11 subcarinal metastasis (31.4%), and 12 lower mediastinal metastasis (34.3%).
    
    
    Conclusion:
    In all mediastinal lymph node metastasis cases , metastasis could emerge in the other locations except for left upper cancers with no lower mediastinal metastasis. It might be acceptable to perform mediastinal lymph node dissection of NSCLC, except for lower mediastinal lymph node in left upper lung cancer. However, further researches with larger amount of cases are required.